SINHA UMA (Chief Scientific Officer) sold 1.5% of their position (5K shares) of EIDOS THERAPEUTICS, INC. on the open market
Open‑market sale worth $261.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 10/2/2020ACC: 0000899243-20-026974
Officer· Chief Scientific Officer
Since Nov 2018
-5K
Net shares
Net seller
$261.7K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
5K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−69.00
Price / share
$52.08
Trade value
$3.59K
% of position
0.0%
9/30/2020
331.52K→331.46K
Common Stock
Direct
Shares
−100.00
Price / share
$52.00
Trade value
$5.20K
% of position
0.0%
9/30/2020
331.46K→331.36K
Common Stock
Direct
Shares
−4.83K
Price / share
$52.35
Trade value
$252.92K
% of position
1.5%
10/1/2020
331.36K→326.52K
Total
Net shares
−5K
Net value
-$261.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2020 | S · Sale | −69.00 | $52.08 | $3.59K | 0.0% | 331.52K | 331.46K |
| Common Stock Direct | 9/30/2020 | S · Sale | −100.00 | $52.00 | $5.20K | 0.0% | 331.46K | 331.36K |
| Common Stock Direct | 10/1/2020 | S · Sale | −4.83K | $52.35 | $252.92K | 1.5% | 331.36K | 326.52K |
| Total | −5K | -$261.72K | ||||||
Derivative Transactions0
No derivative transactions reported